共 43 条
[1]
Adams JM(2004)Ceramide content is increased in skeletal muscle from obese insulin-resistant humans Diabetes 53 25-31
[2]
Pratipanawatr T(2007)Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes Diabetologia 50 2366-2373
[3]
Berria R(2004)Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle Diabetes 53 1215-1221
[4]
Straczkowski M(2008)Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity Diabetologia 51 1253-1260
[5]
Kowalska I(2006)Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 45 42-72
[6]
Baranowski M(2008)Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism Endocr Rev 29 381-402
[7]
Straczkowski M(2008)The role of skeletal muscle sphingolipids in the development of insulin resistance Rev Diabet Stud 5 13-24
[8]
Kowalska I(2007)Key role for ceramides in mediating insulin resistance in human muscle cells J Biol Chem 282 12583-12589
[9]
Nikolajuk A(2007)Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance Cell Metab 5 167-179
[10]
Skovbro M(2009)Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease Diabetologia 58 337-343